Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adults

Young, Andrew L., Challen, Grant A., Birmann, Brenda M., Druley, Todd E.·2016·Nature Communications

Cited by (692)

Items 301–400 of 692

  1. Clonal hematopoiesis driven by somatic mutations: A new player in atherosclerotic cardiovascular disease
    Marta Amorós-Pérez, José J. Fuster · 2020 · Atherosclerosis
  2. Defining clonal hematopoiesis of indeterminate potential: evolutionary dynamics and detection under aging and inflammation
    Elisabeth A. Goldman, Paul T. Spellman, Anupriya Agarwal · 2023 · Molecular Case Studies
  3. PU.1-Dependent Enhancer Inhibition Separates <i>Tet2</i> -Deficient Hematopoiesis from Malignant Transformation
    Aivalioti, Maria M., Bartholdy, Boris A., Pradhan, Kith, Bhagat, Tushar D., Zintiridou, Aliona, Jeong, Jong Jin, Thiruthuvanathan, Victor J., Pujato, Mario, Paranjpe, Aditi, Zhang, Chi et al. · 2022 · Blood Cancer Discovery
  4. CHIPing away the progression potential of CHIP: A new reality in the making
    Zhuoer Xie, Amer Methqal Zeidan · 2022 · Blood Reviews
  5. The Prognostic Significance of Measurable (“Minimal”) Residual Disease in Acute Myeloid Leukemia
    Francesco Buccisano, Christopher Simon Hourigan, Roland B. Walter · 2017 · Current Hematologic Malignancy Reports
  6. Clinical implications of measurable residual disease in AML: Review of current evidence
    Ine Moors, Karl Vandepoele, Jan Philippé, Dries Deeren, Dominik Selleslag, Dimitri A. Breems, Nicole Straetmans, Tessa C. C. Kerre, Barbara Denys · 2018 · Critical Reviews in Oncology/Hematology
  7. The minimal that kills: Why defining and targeting measurable residual disease is the “Sine Qua Non” for further progress in management of acute myeloid leukemia
    Jan Philipp Bewersdorf, Rory Michael Shallis, Prajwal Chaitanya Boddu, Brent Lee Wood, Jerald P. Radich, Stephanie Halene, Amer Methqal Zeidan · 2019 · Blood Reviews
  8. Characterization of TP53 mutations in Pap test DNA of women with and without serous ovarian carcinoma
    Jeffrey D. Krimmel‐Morrison, Talayeh S. Ghezelayagh, Shenyi Lian, Yuezheng Zhang, Jeanne Fredrickson, Daniela Nachmanson, Kathryn Terese Baker, Marc R. Radke, Enna Hun, Barbara M. Norquist et al. · 2019 · Gynecologic Oncology
  9. How aging influences the gut-bone marrow axis and alters hematopoietic stem cell regulation
    Christopher Wells, Tristan Robertson, Prameet M. Sheth, Sheela A. Abraham · 2024 · Heliyon
  10. Association of clonal hematopoiesis and mosaic chromosomal alterations with solid malignancy incidence and mortality
    Pinkal M. Desai, Ying Zhou, Justin E. Grenet, Samuel K. Handelman, Cynthia Crispino, Laura N. Tarbay, Eric A. Whitsel, Gail J. Roboz, Ana Barac, Michael C. Honigberg et al. · 2024 · Cancer
  11. CHIP: a clonal odyssey of the bone marrow niche
    Wolfgang E. Schleicher, Bridget Hoag, Marco De Dominici, James V. DeGregori, Eric Martin Pietras · 2024 · Journal of Clinical Investigation
  12. Somatic Mutations in Aplastic Anemia
    Ghulam Jeelani Mufti, Judith C. W. Marsh · 2018 · Hematology/Oncology Clinics of North America
  13. Somatic Mosaicism in Biology and Disease
    Hayato Ogawa, Keita Horitani, Yasuhiro Izumiya, Soichi Sano · 2021 · Annual Review of Physiology
  14. Mutational landscape of blast phase myeloproliferative neoplasms (MPN-BP) and antecedent MPN
    Sergiu Paşca, Helen T. Chifotides, Srđan Verstovšek, Prithviraj Bose · 2022 · International review of cytology
  15. To portray clonal evolution in blood cancer, count your stem cells
    Anne-Marie Lyne, Lucie Laplane, Leïla Perié · 2020 · Blood
  16. Combined landscape of single-nucleotide variants and copy-number alterations in clonal hematopoiesis
    Ryunosuke Saiki, Yukihide Momozawa, Yasuhito Nannya, Masahiro Marshall Nakagawa, Yotaro Ochi, Tetsuichi Yoshizato, Chikashi Terao, Yutaka Kuroda, Yuichi Shiraishi, Kenichi Chiba et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  17. Chronic TNF in the aging microenvironment exacerbates Tet2 loss-of-function myeloid expansion
    Candice Quin, Erica N. DeJong, Amy J. M. McNaughton, Marco M. Buttigieg, Salman Basrai, Sagi Abelson, MAGGIE J. LARCHÉ, Michael J. Rauh, Dawn M. E. Bowdish · 2024 · Blood Advances
  18. The role of clonal hematopoiesis as driver of therapy-related myeloid neoplasms after autologous stem cell transplantation
    Doriana Gramegna, Diego Bertoli, Chiara M. Cattaneo, Camillo Almici, Alessandro Re, Angelo Belotti, Erika Borlenghi, Gaetana Lanzi, Silvana Archetti, Rosanna Verardi et al. · 2022 · Annals of Hematology
  19. Causes of Clonal Hematopoiesis: a Review
    LiJin Joo, Catherine C. Bradley, Steven Hsesheng Lin, Paul A. Scheet, Kevin Thomas Nead · 2023 · Current Oncology Reports
  20. Understanding the Molecular Basis of Acute Myeloid Leukemias: Where are we Now?
    Alicja Gruszka, Debora Valli, Myriam Alcalay · 2017 · International Journal of Hematologic Oncology
  21. Molecular characteristic of acute leukemias with t(16;21)/FUS-ERG
    Elena Zerkalenkova, Агнеса Владимировна Панферова, А. Н. Казакова, Pavel Baryshev, Larisa Shelihova, И. И. Калинина, Galina A. Novichkova, Michael A Maschan, Aleksey A. Maschan, Yulia V Olshanskaya · 2018 · Annals of Hematology
  22. CHIP: is clonal hematopoiesis a surrogate for aging and other disease?
    Lukasz P. Gondek · 2021 · Hematology
  23. Clonal Hematopoiesis and Premalignant Diseases
    Justin D. Kaner, Pinkal M. Desai, Nuria Mencia-Trinchant, Mónica L. Guzmán, Gail J. Roboz, Duane C. Hassane · 2019 · Cold Spring Harbor Perspectives in Medicine
  24. Oncologic therapy shapes the fitness landscape of clonal hematopoiesis
    Kelly L. Bolton, Ryan N. Ptashkin, Teng Gao, Lior Zvi Braunstein, Sean M. Devlin, Daniel John Kelly, Minal A. Patel, Antonin Berthon, Aijazuddin Syed, Mariko Yabe et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  25. Stem cell mutations can be detected in myeloma patients years before onset of secondary leukemias
    Ashwin Sridharan, Carolina Schinke, George Ivanov Georgiev, Mariana da Silva Ferreira, Victor J. Thiruthuvanathan, Ian C. MacArthur, Tushar Damodar Bhagat, Gaurav S. Choudhary, Srinivas Aluri, Jiahao Chen et al. · 2019 · Blood Advances
  26. Clonal Hematopoiesis, Cardiovascular Diseases and Hematopoietic Stem Cells
    Oleg F. Kandarakov, Alexander V. Belyavsky · 2020 · International Journal of Molecular Sciences
  27. Myelodysplasia Syndrome, Clonal Hematopoiesis and Cardiovascular Disease
    Camilla Bertuzzo Veiga, Erin Lawrence, Andrew James Murphy, Marco J. Herold, Dragana Dragoljevic · 2021 · Cancers
  28. All that glitters is not LGL Leukemia
    Gianpietro Semenzato, Antonella Teramo, Giulia Calabretto, Vanessa Rebecca Gasparini, Renato Zambello · 2022 · Leukemia
  29. Clonal Hematopoiesis: Connecting Aging and Inflammation in Atherosclerosis
    Ariel Héctor Polizio, Eunbee Park, Kenneth Walsh · 2023 · Current Atherosclerosis Reports
  30. Therapeutic targeting of leukemia stem cells in acute myeloid leukemia
    Karina Barbosa, A. Deshpande · 2023 · Frontiers in Oncology
  31. Sequencing paired tumor DNA and white blood cells improves circulating tumor DNA tracking and detects pathogenic germline variants in localized colon cancer
    Francisco Gimeno-Valiente, Jorge Martín-Arana, Roberto Tébar-Martínez, Valentina Gambardella, Carolina Martínez‐Ciarpaglini, Blanca García-Micó, Belén Martínez-Castedo, Brenda Palomar-De Lucas, Miguel García-Bartolomé, Víctor Seguí et al. · 2023 · ESMO Open
  32. Diagnostic and Prognostic Utility of Fluorescence In situ Hybridization (FISH) Analysis in Acute Myeloid Leukemia
    Patrick R. Gonzales, Fady M. Mikhail · 2017 · Current Hematologic Malignancy Reports
  33. Modernizing Human Cancer Risk Assessment of Therapeutics
    Mark R. Fielden, Lucas D. Ward, Sheroy Minocherhomji, Paul Nioi, Herve N. Lebrec, David Jacobson‐Kram · 2017 · Trends in Pharmacological Sciences
  34. Development of a Novel Next-Generation Sequencing Assay for Carrier Screening in Old Order Amish and Mennonite Populations of Pennsylvania
    Erin Lynn Crowgey, Michael C. Washburn, Edward Anders Kolb, Erik G. Puffenberger · 2019 · Journal of Molecular Diagnostics
  35. Role of DNA Damage Response in Suppressing Malignant Progression of Chronic Myeloid Leukemia and Polycythemia Vera: Impact of Different Oncogenes
    Jan Stetka, Ján Gurský, Julie Liñan Velasquez, Renata Mojzíková, Pavla Vyhlidalova, Lucia Vráblová, Jiří Bártek, Vladimír Divoký · 2020 · Cancers
  36. Quantification of cancer driver mutations in human breast and lung DNA using targeted, error‐corrected CarcSeq
    Kelly L. Harris, Vijay Walia, Bin-Sheng Gong, Karen L. McKim, Meagan B. Myers, Joshua Xu, Barbara L. Parsons · 2020 · Environmental and Molecular Mutagenesis
  37. Clonal haematopoiesis is not prevalent in survivors of childhood cancer
    Grace Collord, Naomi Park, Marina Podestà, Monica Dagnino, Daniela Cilloni, David Jones, Ignacio Varela, Francesco Frassoni, George S. Vassiliou · 2017 · British Journal of Haematology
  38. CML - Not only BCR-ABL1 matters
    Jenny Rinke, Andreas Hochhaus, Thomas Ernst · 2020 · Best Practice & Research Clinical Haematology
  39. Importance of clonal hematopoiesis in heart failure
    Nicholas W. Chavkin, Kyung-Duk Min, Kenneth Walsh · 2021 · Trends in Cardiovascular Medicine
  40. Biomarkers in Acute Myeloid Leukemia: Leveraging Next Generation Sequencing Data for Optimal Therapeutic Strategies
    Hanadi El Achi, Rashmi Kanagal‐Shamanna · 2021 · Frontiers in Oncology
  41. Clonal hematopoiesis in the donor does not adversely affect long-term outcomes following allogeneic hematopoietic stem cell transplantation: result from a 13-year follow-up
    Kyoung Ha Kim, Tae‐Hyung Kim, Igor Novitzky‐Basso, Hyewon Lee, Youngseok Yoo, Jae‐Sook Ahn, Ivan Pašić, Arjun Law, Wilson Lam, Fotios V. Michelis et al. · 2023 · Haematologica
  42. Tissue mosaicism following stem cell aging: blood as an exemplar
    Chiraag Deepak Kapadia, Margaret A. Goodell · 2024 · Nature Aging
  43. Technical Validation and Clinical Utility of an NGS Targeted Panel to Improve Molecular Characterization of Pediatric Acute Leukemia
    Clara Vicente‐Garcés, Elena Esperanza‐Cebollada, Sara Montesdeoca, Montserrat Torrebadell, Susana Rives, José Luís Dapena, Albert Català, Núria Conde, Mireia Camós, Nerea Vega‐García · 2022 · Frontiers in Molecular Biosciences
  44. Clonal hematopoiesis of indeterminate potential and cardiovascular disease
    Seyedmohammad Saadatagah, Christie Mitchell Ballantyne · 2022 · Translational research
  45. Clonal Hematopoiesis of Indeterminate Potential as a Novel Risk Factor for Donor-Derived Leukemia
    Sarah S. Burns, Reuben Kapur · 2020 · Stem Cell Reports
  46. Precocious clonal hematopoiesis in Down syndrome is accompanied by immune dysregulation
    L. Alexander Liggett, Matthew D. Galbraith, Keith P. Smith, Kelly D. Sullivan, Ross E. Granrath, Belinda A Enriquez Estrada, Kohl T. Kinning, Jessica R. Shaw, Angela L. Rachubinski, Joaquin Maximiliano Espinosa et al. · 2021 · Blood Advances
  47. Rationale and Roadmap for Developing Panels of Hotspot Cancer Driver Gene Mutations as Biomarkers of Cancer Risk
    Kelly L. Harris, Meagan B. Myers, Karen L. McKim, Rosalie K. Elespuru, Barbara L. Parsons · 2019 · Environmental and Molecular Mutagenesis
  48. Harnessing the potential of epigenetic therapies for childhood acute myeloid leukemia
    Ashley Newcombe, Brenda E. S. Gibson, Karen Keeshan · 2018 · Experimental Hematology
  49. Clonal approaches to understanding the impact of mutations on hematologic disease development
    Jyoti Nangalia, Emily Mitchell, Anthony Richard Green · 2019 · Blood
  50. Clonal tracking of haematopoietic cells: insights and clinical implications
    Stefan Cordes, Chuanfeng Wu, Cynthia E. Dunbar · 2020 · British Journal of Haematology
  51. Clonal hematopoiesis and vascular disease
    Kaushik V Amancherla, John A. Wells, Alexander G. Bick · 2022 · Seminars in Immunopathology
  52. Molecular Pathways in Clonal Hematopoiesis: From the Acquisition of Somatic Mutations to Transformation into Hematologic Neoplasm
    Charles Gaulin, Katalin Kelemen, Cecilia Arana Yi · 2022 · Life
  53. Prevalence, mutational spectrum and clinical implications of clonal hematopoiesis of indeterminate potential in plasma cell dyscrasias
    Stefano Testa, Jyoti Kumar, Alex J. Goodell, James L. Zehnder, Kevin Michael Alexander, Surbhi Sidana, Sally Arai, Ronald M. Witteles, Michaela Liedtke · 2022 · Seminars in Oncology
  54. Clonal Hematopoiesis of Indeterminate Potential and its Association with Treatment Outcomes and Adverse Events in Patients with Solid Tumors
    Tharani Krishnan, João Paulo Solar Vasconcelos, Emma Titmuss, Robert J. Vanner, David F. Schaeffer, Aly Karsan, Howard John Lim, Cheryl Ho, Sharlene Gill, Stephen S. F. Yip et al. · 2024 · Cancer Research Communications
  55. Clonal hematopoiesis in myeloid malignancies and solid tumors
    Xiurong Cai, Robert L. Bowman, Jennifer J. Trowbridge · 2025 · Nature Cancer
  56. Epigenetic and proteomic signatures associate with clonal hematopoiesis expansion rate
    Taralynn Mack, Michael A. Raddatz, Yash Pershad, Daniel C. Nachun, Kent D. Taylor, Xiuqing Guo, Alan R. Shuldiner, Jeffrey R. O’Connell, Eimear E. Kenny, Ruth J. F. Loos et al. · 2024 · Nature Aging
  57. Immune Aging and Its Implication for Age-Related Disease Progression
    Yuki Sato · 2025 · Physiology
  58. Acquired Aplastic Anemia as a Clonal Disorder of Hematopoietic Stem Cells
    Katarzyna Brzeźniakiewicz‐Janus, Joanna Rupa‐Matysek, Lidia Gil · 2020 · Stem Cell Reviews and Reports
  59. Chemotherapy-associated clonal hematopoiesis mutations should be taken seriously in plasma cell-free DNA KRAS/NRAS/BRAF genotyping for metastatic colorectal cancer
    Fei Huang, Yihui Yang, Xinning Chen, Huiqin Jiang, Hao Wang, Minna Shen, Yiyi Yu, Tianshu Liu, Baishen Pan, Beili Wang et al. · 2021 · Clinical Biochemistry
  60. Measurable Residual Disease Assessment as a Surrogate Marker in New Drug Development in Acute Myeloid Leukemia
    Gege Gui, Christopher S. Hourigan · 2022 · The Cancer Journal
  61. Expansion of mutation-driven haematopoietic clones is associated with insulin resistance and low HDL-cholesterol in individuals with obesity
    Rosanne C. van Deuren, Johanna C. Andersson-Assarsson, Felipe M. Kristensson, Marloes Steehouwer, Kajsa Sjöholm, Per-Arne Svensson, Marc Pieterse, Christian Gilissen, Magdalena Taube, Peter Jacobson et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  62. Clonal evolution in patients developing therapy-related myeloid neoplasms following autologous stem cell transplantation
    Johannes Frasez Soerensen, Anni Aggerholm, Carina Agerbo Rosenberg, Marie Bill, Gitte Birk Kerndrup, Lene Hyldahl Ebbesen, Marcus Høy Hansen, Anne Stidsholt Roug, Maja Ludvigsen · 2022 · Bone Marrow Transplantation
  63. Characterization of clonal dynamics using duplex sequencing in donor-recipient pairs decades after hematopoietic cell transplantation
    Masumi Ueda, Jacob E. Higgins, Isaac Jenkins, Timothy W. Randolph, Thomas Horace Smith, Charles C. Valentine, Jesse J. Salk, Cecilia C.S. Yeung, Lan W. Beppu, Judy Campbell et al. · 2024 · Science Translational Medicine
  64. Clonal hematopoiesis of indeterminate potential (CHIP) in cerebromicrovascular aging: implications for vascular contributions to cognitive impairment and dementia (VCID)
    Attila Kállai, Anna Ungvari, Dóra Csabán, Zoltán Őrfi, Andrea Lehoczki, József Harasztdombi, Andriy Yabluchanskiy, Zoltán Benyó, Ágnes Szappanos, Stefano Tarantini et al. · 2025 · GeroScience
  65. UMI-Gen: A UMI-based read simulator for variant calling evaluation in paired-end sequencing NGS libraries
    Vincent Sater, Pierre‐Julien Viailly, Thierry Lecroq B, Philippe Ruminy, Caroline Bérard, Élise Prieur-Gaston, Fabrice Jardin · 2020 · Computational and Structural Biotechnology Journal
  66. Studying clonal evolution of myeloid malignancies using induced pluripotent stem cells
    Sergei R. Doulatov, Eirini P. Papapetrou · 2020 · Current Opinion in Hematology
  67. Myelodysplastic syndromes: Biological and therapeutic consequences of the evolving molecular aberrations landscape
    Sebastian Schwind, Madlen Jentzsch, Anne Sophie Kubasch, Klaus Hans Metzeler, Uwe Platzbecker · 2021 · Neoplasia
  68. Therapy-Related Clonal Hematopoiesis
    Yoshimitsu Yura, Jesse D. Cochran, Kenneth Walsh · 2022 · Heart Failure Clinics
  69. L’hématopoïèse clonale : un concept émergent à la croisée des spécialités
    François‐Xavier Danlos, Matthias Papo, Jean‐Baptiste Micol · 2019 · La Revue de Médecine Interne
  70. Getting personal with myelodysplastic syndromes: is now the right time?
    Nora Chokr, Alexander B. Pine, Jan Philipp Bewersdorf, Rory Michael Shallis, Maximilian F. Stahl, Amer Methqal Zeidan · 2019 · Expert Review of Hematology
  71. From bone marrow failure syndromes to VEXAS: Disentangling clonal hematopoiesis, immune system, and molecular drivers
    Carmelo Gurnari, Valeria Visconte · 2023 · Leukemia Research
  72. ArCH: improving the performance of clonal hematopoiesis variant calling and interpretation
    Irenaeus C.C. Chan, Alex Panchot, Evelyn Schmidt, Samantha N. McNulty, Brian J. Wiley, Jie Liu, Kimberly Turner, Lea A. Moukarzel, Wendy S W Wong, Duc Tran et al. · 2024 · Bioinformatics
  73. A feedback loop: Interactions between Inflammatory Signals and Clonal Hematopoiesis in Cardiovascular Disease
    Jiashan Li, Chao Wang, Jiaru Liu, Ying Yu, Yuee Liu, Qi Peng, Huihui Liu, Xiuru Guan · 2021 · Molecular Biology Reports
  74. Game of clones: Diverse implications for clonal hematopoiesis in lymphoma and multiple myeloma
    Jeremy Meier, Jeffrey Lee Jensen, Christopher E. Dittus, Catherine Callaghan Coombs, Samuel M. Rubinstein · 2022 · Blood Reviews
  75. The spectrum of somatic mutations in large granular lymphocyte leukemia, rheumatoid arthritis, and Felty's syndrome
    Paula Savola, Dipabarna Bhattacharya, Jani Huuhtanen · 2022 · Seminars in Hematology
  76. Rare Event Detection Using Error-corrected DNA and RNA Sequencing
    Winghing Wong, R. Spencer Tong, Andrew L. Young, Todd E. Druley · 2018 · Journal of Visualized Experiments
  77. Targeted, Amplicon-Based, Next-Generation Sequencing to Detect Age-Related Clonal Hematopoiesis
    Brooke Snetsinger, Christina K. Ferrone, Michael J. Rauh · 2019 · Methods in molecular biology
  78. Mutations in myelodysplastic syndromes: Core abnormalities and CHIPping away at the edges
    Gabriel C. Caponetti, Adam Bagg · 2020 · International Journal of Laboratory Hematology
  79. Clonal hematopoiesis in hematopoietic stem cell transplantation
    Christian Matthias Wilk, Markus Gabriel Manz, Steffen Boettcher · 2020 · Current Opinion in Hematology
  80. Inflammation reprogramming and immunomodulation: Next-generation treatments for atherosclerosis
    Robin P. Choudhury, Rupen Hargreaves, Jason Chai, Edward A A Fisher · 2025 · Cell Reports Medicine
  81. Clonal Hematopoiesis in Cancer and Cardiovascular Disease
    Megan A. Evans, Kenneth X. Walsh · 2025 · JACC CardioOncology
  82. Unravelling the genetics and epigenetics of the ageing tumour microenvironment in cancer
    Hariharan Easwaran, Ashani T. Weeraratna · 2025 · Nature reviews. Cancer
  83. Clonal Haematopoiesis is Associated with Major Adverse Cardiovascular Events in Patients with Hypertrophic Cardiomyopathy
    Fernando Luís Scolari, Darshan H. Brahmbhatt, Sagi Abelson, Deacon Z. J. Lee, Raymond H. Kim, Ali Pedarzadeh, Ali Sakhnini, Arnon Adler, Raymond Ho Ming Chan, John Edgar Dick et al. · 2024 · European Journal of Heart Failure
  84. Pitfalls in molecular diagnostics
    Lulu Sun, John D. Pfeifer · 2019 · Seminars in Diagnostic Pathology
  85. Paired bone marrow and peripheral blood samples demonstrate lack of widespread dissemination of some CH clones
    Afaf E.G. Osman, Nuria Mencia-Trinchant, Caner Saygin, Luke Moma, Aelin Kim, Genevieve Housman, Matthew J. Pozsgai, Eti Sinha, Pooja Chandra, Duane C. Hassane et al. · 2022 · Blood Advances
  86. The role of clonal haematopoiesis in cardiovascular diseases: epidemiology and experimental studies
    K. D. Min, Anupreet Kour, Soichi Sano, Kenneth Walsh · 2020 · Journal of Internal Medicine
  87. Deciphering TP53 mutant Cancer Evolution with Single-Cell Multi-Omics
    Alba Rodríguez-Meira, Ruggiero Norfo, Wei Xiong Wen, Agathe L. Chédeville, Haseeb Rahman, Jennifer O’Sullivan, Guanlin Wang, Eleni Louka, Warren W. Kretzschmar, Aimee Paterson et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  88. CDK4/6 inhibition mitigates chemotherapy-induced expansion of TP53-mutant clonal hematopoiesis
    Irenaeus C.C. Chan, Pu Zhang, Xiangyu Pan, Cynthia Castro, Nina Fox, Alexander M. Lewis, Kenyon Weis, Maria Adriana Cuibus, Steven Tittley, Giulia E.M. Petrone et al. · 2026 · Nature Genetics
  89. Considering clonal hematopoiesis of indeterminate potential in space radiation risk analysis for hematologic cancers and cardiovascular disease
    Charles M. Werneth, Zarana S. Patel, Moriah S. Thompson, Steve R. Blattnig, Janice L. Huff · 2024 · Communications Medicine
  90. Clinical and Therapeutic Implications of Clonal Hematopoiesis
    Giulia E.M. Petrone, Isik Turker, Pradeep Natarajan, Kelly L. Bolton · 2024 · Annual Review of Genomics and Human Genetics
  91. The emergence of clonal hematopoiesis as a disease determinant
    Kenneth Walsh · 2024 · Journal of Clinical Investigation
  92. Biomarkers in clonal haematopoiesis of indeterminate potential (CHIP) linking cardiovascular diseases, myeloid neoplasms and inflammation
    Hui Shan Valerie Tan, Haowen Jiang, Samuel Sherng Young Wang · 2025 · Annals of Hematology
  93. Modelling the ageing dependence of cancer evolutionary trajectories
    Curtis James Henry, James V. DeGregori · 2025 · Nature reviews. Cancer
  94. Genetic Heterogeneity in Chronic Myeloid Leukemia: How Clonal Hematopoiesis and Clonal Evolution May Influence Prognosis, Treatment Outcome, and Risk of Cardiovascular Events
    Emanuela Sant’Antonio, Chiara Camerini, Vincenzo Rizzo, Caterina Musolino, Alessandro Allegra · 2021 · Clinical Lymphoma Myeloma & Leukemia
  95. The Opportunities and Challenges of Molecular Tagging Next-Generation Sequencing in Liquid Biopsy
    Giuseppa De Luca, Mariella Dono · 2021 · Molecular Diagnosis & Therapy
  96. Enriched clonal hematopoiesis in seniors with dietary vitamin C inadequacy
    Jiaqi Chen, Daijing Nie, Xinyu Wang, Lei Wang, Fang Wang, Yang Zhang, Chen Xue, Panxiang Cao, Minghua Li, Xiaoli Ma et al. · 2021 · Clinical Nutrition ESPEN
  97. Association between abnormal lipid profile and inflammation and progression of myelodysplastic syndrome to acute leukemia
    Wei Qiao, Elliana J. Young, Feng Chun, Suyu Liu, Jeff Jin, Laila Z. Noor, Cristhiam Mauricio Rojas Hernandez, Gautam M. Borthakur, Olga Y. Gorlova, Vahid Afshar‐Kharghan · 2022 · Experimental Hematology and Oncology
  98. Molecular Diagnostic Testing for Hematopoietic Neoplasms
    Christopher A. Hergott, Annette S. Kim · 2022 · Clinics in Laboratory Medicine
  99. Homological Landscape of Human Brain Functional Sub-Circuits
    Duy Anh Duong-Tran, Ralph M. Kaufmann, Jiong Chen, Xuan Wang, Sumita Garai, Frederick H. Xu, Jingxuan Bao, Enrico Amico, Alan David Kaplan, Giovanni Petri et al. · 2024 · Mathematics
  100. Time to Move to the Single-Cell Level: Applications of Single-Cell Multi-Omics to Hematological Malignancies and Waldenström’s Macroglobulinemia—A Particularly Heterogeneous Lymphoma
    Ramón García‐Sánz, Cristina Jiménez · 2021 · Cancers